EPS

Orange unveils its 'Trust the future' plan, targeting €5.2B in cash flow by 2028, powered by its MasOrange unit and a major push into AI and digital services.

The NYSE-listed medtech firm will detail its "ecosystem" strategy for the booming shoulder surgery market amid rapid revenue growth and a push for profitability.

Reddy Ice has acquired rival Arctic Glacier, creating an industry giant. The deal, shaped by antitrust regulators, reshapes the continent's frozen landscape.

Carmila's 2025 results reveal a powerful strategy of innovation and acquisition, driving record profits and hinting at a broader market recovery.

SSR Mining unveils a bold financial strategy, redeeming $227M in debt while launching a new $300M stock buyback, signaling strong confidence to investors.

The research giant took a massive Q4 loss from asset impairments but points to improving client demand and a strategic overhaul as signs of a turnaround.

The specialty chemicals firm saw a full-year revenue dip but ended 2025 with strong cash flow and signs of a turnaround in its struggling divisions.

New discoveries and record gold reserves at Ecuador's Fruta del Norte mine signal a golden future, extending its life and boosting investor confidence.

RV giant THOR Industries' upcoming Q2 earnings are a critical test for consumer spending as interest rate cuts battle cautious sentiment and market shifts.

Goosehead Insurance posts strong 16% revenue growth but lower net income, betting big on its new digital platform and AI to justify heavy spending.

Amid market volatility, the S&P 500 firm reinforces its financial strength with a massive share repurchase program and its 34th year of dividend growth.

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

With strong 2025 results, packaging leader Ball Corp will address investors on its financial outlook and its central role in the sustainable materials market.

USANA posts higher 2025 sales fueled by its Hiya and Rise brands, but a Q4 loss and a shrinking core business reveal the high cost of its transformation.

As executives head to the BMO Global Metals Conference, Reliance navigates a mixed earnings report, industry consolidation, and a critical minerals boom.

The firm beat Q4 revenue guidance but faces a soft outlook, doubling down on a futuristic AI strategy and aggressive shareholder returns to navigate volatility.

Facing massive revenue declines and a shrinking coach network due to GLP-1 drugs, Medifast bets its future on a risky pivot from weight loss to metabolic health.

Following a year of robust earnings and a 10% dividend hike, Great-West Lifeco's CEO is set to detail the firm's future plans in a key investor chat.

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

Landmark study in JAMA Neurology shows BRIUMVI offers near-zero relapse rates and stable disability, reshaping long-term multiple sclerosis treatment.